1)日本食道学会(編):食道癌診断・治療ガイドライン2012年4月版,金原出版
2)馬場秀夫,藏重淳二,木下浩一,他:切除可能食道癌に対する術前化学放射線療法.消外33:1297-1303, 2010
3)Walsh TN, Noonan N, Hollywood D, et al:A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467, 1996
4)Tepper J, Krasna MJ, Niedzwiecki D, et al:Phase Ⅲ trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer:CALGB 9781. J Clin Oncol 26:1086-1092, 2008
5)Bosset JF, Gignoux M, Triboulet JP, et al:Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161-167, 1997
6)Burmeister BH, Smithers BM, Gebski V, et al:Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus:a randomised controlled phase Ⅲ trial. Lancet Oncol 6:659-668, 2005
7)Gebski V, Burmeister B, Smithers BM, et al:Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma:a meta-analysis. Lancet Oncol 8:226-234, 2007
8)Sjoquist KM, Burmeister BH, Smithers BM, et al:Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma:an updated meta-analysis. Lancet Oncol 12:681-692, 2011
9)Stahl M, Stuschke M, Lehmann N, et al:Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310-2317, 2005
10)Bonnetain F, Bouché O, Michel P, et al:A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase Ⅲ trial (FFCD 9102):chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 17:827-834, 2006
11)Stahl M, Walz MK, Stuschke M, et al:Phase Ⅲ comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 27:851-856, 2009
12)Nakamura K, Kato K, Igaki H, et al:Three-arm phase Ⅲ trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study). Jpn J Clin Oncol 43:752-755, 2013
13)Van Cutsem E, Moiseyenko VM, Tjulandin S, et al:Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group. J Clin Oncol 24:4991-4997, 2006
14)Posner MR, Hershock DM, Blajman CR, et al:Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705-1715, 2007
15)Lorenzen S, Brücher B, Zimmermann F, et al:Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma:results of a phase Ⅰ/Ⅱ trial. Br J Cancer 99:1020-1026, 2008
16)Arnott SJ, Duncan W, Gignoux M, et al:Preoperative radiotherapy in esophageal carcinoma:a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 41:579-583, 1998
17)Iizuka T, Ide H, Kakegawa T, et al:Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 93:1054-1058, 1988
18)Ténière P, Hay JM, Fingerhut A, et al:Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 173:123-130, 1991
19)Fok M, Sham JS, Choy D, et al:Postoperative radiotherapy for carcinoma of the esophagus:a prospective, randomized controlled study. Surgery 113:138-147, 1993